Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK; Department of Orthopaedics, Medical University of Vienna, Vienna, Austria.
Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Acta Orthop. 2024 Nov 29;95:707-714. doi: 10.2340/17453674.2024.42360.
We aimed to compare the effect of calcium sulphate (CS) beads loaded with antibiotics on infection eradication in debridement, antibiotics, and implant retention (DAIR) of periprosthetic joint infection relative to DAIR without local antibiotics delivery.
176 patients with hip or knee arthroplasty undergoing DAIR were retrospectively identified and divided into a bead group (n = 102) and a control group (n = 74). Infections were classified as early postoperative, acute hematogenous, and chronic. Logistic regression analyses were performed on the use of CS beads. Revision-free and infection-free survival was estimated using Kaplan-Meier analysis.
Reinfection occurred in 36% of the bead group, and 39% of the control group (odds ratio [OR] 0.9, 95% confidence interval [CI] 0.5- 1.6); reoperation rates were 34% and 43% (OR 0.7, CI 0.4-1.3). Kaplan-Meier analysis showed no statistically significant difference between the 2 groups regarding infection-free (HR 1.1, CI 0.7-1.8) and revision-free (HR 1.1, CI 0.7-1.9) survival rates. In acute hematogenous PJIs, reinfection (29% vs 56%, OR 0.3, CI 0.1-1.1) and reoperation rates (25% vs 61%, OR 0.2, CI 0.1-0.8) were reduced when CS beads were used; Kaplan-Meier analysis revealed higher infection-free (HR 0.5, CI 0.2-1.4) and revision-free (HR 0.5, CI 0.2-1.3) survival rates in the bead group but not of statistical significance. Wound drainage was not increased by CS beads use (OR 1.0, CI 0.99-1.01), but hypercalcemia was seen in 9% in the bead group.
DAIR with antibiotic-loaded CS beads did not improve outcome in early postoperative and chronic PJIs, but reduced the reoperation rate in acute haematogenous infections with similar results compared with early postoperative PJIs.
我们旨在比较在清创术、抗生素和假体保留(DAIR)中使用载抗生素硫酸钙(CS)珠治疗假体周围关节感染(PJI)与不局部使用抗生素治疗相比,对感染清除的效果。
回顾性分析了 176 例接受 DAIR 的髋关节或膝关节置换术患者,将其分为珠组(n = 102)和对照组(n = 74)。感染分为术后早期、急性血源性和慢性。对 CS 珠的使用进行了逻辑回归分析。采用 Kaplan-Meier 分析估计无翻修和无感染生存率。
珠组再感染率为 36%,对照组为 39%(比值比[OR]0.9,95%置信区间[CI]0.5-1.6);再手术率分别为 34%和 43%(OR 0.7,CI 0.4-1.3)。Kaplan-Meier 分析显示,两组在无感染(HR 1.1,CI 0.7-1.8)和无翻修(HR 1.1,CI 0.7-1.9)生存率方面无统计学差异。在急性血源性 PJI 中,使用 CS 珠可降低再感染(29% vs 56%,OR 0.3,CI 0.1-1.1)和再手术率(25% vs 61%,OR 0.2,CI 0.1-0.8);Kaplan-Meier 分析显示珠组无感染(HR 0.5,CI 0.2-1.4)和无翻修(HR 0.5,CI 0.2-1.3)生存率较高,但无统计学意义。CS 珠的使用并未增加伤口引流(OR 1.0,CI 0.99-1.01),但珠组有 9%出现高钙血症。
在术后早期和慢性 PJI 中,DAIR 联合载抗生素 CS 珠并未改善预后,但在急性血源性感染中降低了再手术率,且与术后早期 PJI 结果相似。